trending Market Intelligence /marketintelligence/en/news-insights/trending/tU46YCoRW00T-l9ZGeEhrg2 content esgSubNav
In This List

Spring Bank Pharmaceuticals replaces chairman; director steps down

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Spring Bank Pharmaceuticals replaces chairman; director steps down

Spring Bank Pharmaceuticals Inc. named Scott Smith to be the company's chairman, effective Jan. 1, 2019.

Smith will replace Martin Driscoll, who will continue as the company's president and CEO.

Meanwhile, Christiana Bardon stepped down as a director of the U.S.-based clinical-stage biopharmaceutical company.